Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled study

The researchers compared three distinct exercise modalities against a no-exercise control group:

**Aerobic endurance training (AET):** Continuous running at 60–70% of heart rate reserve (moderate intensity), three 45-minute sessions per week.

**High-intensity interval training (IT):** The "4×4 method" — four 4-minute intervals at 90–95% of maximum heart rate, separated by 3 minutes of active recovery at 60–70% of maximum heart rate, three 45-minute sessions per week.

**Resistance training (RT):** Circuit training on eight different resistance machines (e.g., leg press, chest press, lat pulldown), three 45-minute sessions per week, at 60–80% of one-repetition maximum.

The control group was instructed to maintain their usual lifestyle with no changes in physical activity.

The primary outcomes were:

1. **Telomerase activity** in blood mononuclear cells (immune cells) — measured as the enzyme's ability to add DNA repeats to telomeres.

2. **Telomere length** in lymphocytes, granulocytes, and total leukocytes — measured as the average length of the protective caps at chromosome ends.

Secondary outcomes included:

Maximum oxygen uptake (VO₂max) — a measure of cardiorespiratory fitness.

Acute effects of a single exercise bout on telomerase activity in specific immune cell subtypes (CD14+ monocytes and CD34+ progenitor cells).

**Sample size:** 124 healthy, previously inactive adults completed the 6-month study (from an initial 266 screened, 166 enrolled, 124 completed).

**Age range:** 30–60 years (mean age ~45 years).

**Sex:** 62% female, 38% male.

**Baseline activity:** "Previously inactive" — defined as exercising less than once per week for the past 2 years.

**Health status:** Non-smokers, no chronic diseases (cardiovascular, metabolic, inflammatory), no regular medication use, no contraindications to exercise testing.

**Setting:** University hospital in Germany (Saarland University). Participants were recruited via public advertisements.

**Telomerase activity:** Measured using the TRAP (Telomeric Repeat Amplification Protocol) assay on protein extracts from peripheral blood mononuclear cells (PBMCs). Results expressed as relative telomerase activity compared to a control cell line (293T cells). For the acute exercise experiment, they used MACS-TRAP (magnet-activated cell sorting combined with TRAP) to isolate CD14+ monocytes and CD34+ progenitor cells.

**Telomere length:** Measured using quantitative real-time PCR (qPCR) on DNA from isolated lymphocytes, granulocytes, and total leukocytes. Results expressed as the telomere-to-single-copy-gene ratio (T/S ratio), a relative measure where higher values indicate longer telomeres.

**Cardiorespiratory fitness:** VO₂max measured via a graded treadmill test to exhaustion using a metabolic cart (breath-by-breath gas analysis).

**Exercise adherence:** Monitored via heart rate monitors during training sessions and training logs. Supervised sessions were held at the university's exercise facility.

**Blood sampling:** Fasting blood samples were collected at baseline, after 3 months, and after 6 months. For the acute exercise experiment, blood was drawn before, immediately after, and 1 hour after a single training session.

**Study design:** This was a prospective, randomized, controlled, parallel-group trial with four arms (AET, IT, RT, and control). Participants were randomly assigned using a computer-generated randomization sequence with stratification by sex and age.

**Randomization:** Yes — participants were randomly allocated to one of four groups. The randomization sequence was generated by a statistician not involved in recruitment or training supervision. Allocation concealment was achieved using sealed, opaque envelopes.

**Blinding:** This was an **open-label** study. Neither participants nor trainers were blinded to group assignment (you cannot realistically blind someone to whether they are running or lifting weights). However, the laboratory technicians who performed the telomerase and telomere length assays were blinded to group allocation. The researchers who analyzed the data were also blinded to group identity until after the primary analyses were completed.

**Duration:** 6 months of training (three sessions per week, 45 minutes each), plus a single acute exercise bout experiment conducted at the end of the training period.

**Statistical approach:** The primary analysis used a mixed-effects model for repeated measures (MMRM) with group, time, and group-by-time interaction as fixed effects, and baseline values as covariates. Post-hoc comparisons used Tukey's test to adjust for multiple comparisons. Sample size was calculated a priori: they estimated that 30 participants per group would provide 80% power to detect a 1.5-fold difference in telomerase activity between groups (based on pilot data).

**What this design can and cannot prove:**

**Can prove:** Causal effects of exercise modality on telomerase activity and telomere length, because of the randomized, controlled design. Randomization ensures that differences between groups at 6 months are due to the training, not pre-existing differences. The control group accounts for natural changes over time (e.g., seasonal effects, aging).

**Cannot prove:** Mechanisms — the study shows that endurance training increases telomerase, but not *how* (e.g., via reduced oxidative stress, improved mitochondrial function, or altered gene expression). It also cannot prove long-term health outcomes (e.g., reduced mortality or disease risk) because it only measured cellular markers. The acute exercise experiment (single bout) can show immediate effects but not whether these acute bursts accumulate into lasting changes.

**Major methodological weaknesses:**

**No blinding of participants or trainers** — this introduces potential for placebo effects or differential motivation, though objective biomarkers (telomerase, telomere length) are less susceptible to bias than self-reported outcomes.

**High dropout rate** — 42 of 166 enrolled participants (25%) did not complete the study. If dropouts differed systematically between groups (e.g., more dropouts in the interval training group due to perceived difficulty), this could bias results. The authors report that dropouts did not differ from completers in baseline characteristics, but this is not a guarantee.

**Single-center study** — results may not generalize to other populations, settings, or exercise protocols.

**No dietary control** — participants were not instructed to change their diet, but dietary intake was not monitored. Changes in diet could confound results (e.g., caloric restriction also increases telomerase activity).

**Telomere length measured in blood cells only** — these may not reflect telomere dynamics in other tissues (e.g., muscle, brain, heart).

**Primary outcomes (telomerase activity and telomere length):**

**Telomerase activity in PBMCs increased significantly in both endurance groups but not in resistance training:**

- AET (endurance): 2.9-fold increase from baseline at 6 months (p < 0.001 vs. control)

- IT (interval): 2.2-fold increase from baseline at 6 months (p < 0.001 vs. control)

- RT (resistance): No significant change (1.1-fold, p = 0.68 vs. control)

- Control: No significant change (1.0-fold)

- The difference between AET and IT was not statistically significant (p = 0.21)

**Telomere length increased in lymphocytes, granulocytes, and total leukocytes in both endurance groups:**

- Lymphocyte telomere length (T/S ratio): AET increased by 0.12 ± 0.04 (p = 0.003 vs. control); IT increased by 0.10 ± 0.04 (p = 0.01 vs. control); RT showed no change (p = 0.82)

- Granulocyte telomere length: AET increased by 0.14 ± 0.05 (p = 0.002); IT increased by 0.11 ± 0.05 (p = 0.02); RT no change

- Leukocyte telomere length: AET increased by 0.13 ± 0.04 (p = 0.001); IT increased by 0.10 ± 0.04 (p = 0.01); RT no change

- For context, a T/S ratio change of 0.10–0.14 is roughly equivalent to reversing ~4–6 years of age-related telomere shortening (based on cross-sectional data showing telomeres shorten by ~0.02–0.03 T/S units per year).

**Telomerase activity and telomere length changes were correlated:** Across all participants, the increase in telomerase activity at 6 months was positively correlated with the increase in telomere length (r = 0.41, p < 0.001), suggesting the enzyme activity drove the lengthening.

**Secondary outcomes:**

**VO₂max increased in all three training groups:**

- AET: +15% (from 32.1 to 36.9 mL/kg/min, p < 0.001 vs. control)

- IT: +18% (from 31.8 to 37.5 mL/kg/min, p < 0.001 vs. control)

- RT: +8% (from 32.4 to 35.0 mL/kg/min, p = 0.02 vs. control)

- Control: No change (32.0 to 31.8 mL/kg/min)

- The increase in IT was significantly greater than in RT (p = 0.01), but not significantly different from AET (p = 0.34).

**Acute exercise bout effects (measured after a single session at the end of the 6-month training period):**

- A single bout of endurance training (AET) increased telomerase activity in CD14+ monocytes by 2.1-fold immediately post-exercise (p = 0.002) and by 1.8-fold at 1 hour post-exercise (p = 0.01).

- A single bout of endurance training increased telomerase activity in CD34+ progenitor cells by 1.7-fold immediately post-exercise (p = 0.02).

- A single bout of resistance training (RT) showed no significant change in telomerase activity in either cell type (p > 0.05 for all time points).

- Interval training was not tested in the acute bout experiment.

To put these numbers in perspective:

**Telomerase activity:** A 2–3 fold increase means that after 6 months of endurance or interval training, the enzyme that rebuilds telomeres was 2–3 times more active than at baseline. This is roughly the same magnitude of increase seen with 12 weeks of intensive lifestyle modification (diet + exercise + stress reduction) in other studies, or with certain pharmacological interventions in animal models.

**Telomere length:** The increase of 0.10–0.14 T/S units in lymphocytes is equivalent to reversing approximately 4–6 years of age-related telomere shortening. For context, telomeres typically shorten by about 0.02–0.03 T/S units per year in healthy adults. So 6 months of endurance training effectively "reversed" about 4–6 years of cellular aging in these immune cells.

**VO₂max:** The 15–18% increase in endurance and interval groups is substantial — equivalent to going from "below average" fitness for a 45-year-old to "above average." This is comparable to the improvement seen with 6 months of moderate-to-vigorous aerobic training in previously sedentary adults.

**Resistance training vs. endurance:** Resistance training improved VO₂max by only 8% (half the improvement of endurance training) and had no effect on telomerase or telomeres. This suggests that the cellular anti-aging benefits are specific to aerobic exercise, not just any physical activity.

**Acknowledged by authors:**

Open-label design (no participant blinding) — though objective biomarkers reduce bias risk.

Single-center study — may not generalize to other populations or settings.

Telomere length measured only in blood cells — not in other tissues.

No measurement of oxidative stress or inflammation markers that could mediate the effects.

The acute exercise experiment only tested endurance and resistance training, not interval training.

**Additional critical notes:**

**High dropout rate (25%)** — if dropouts were more likely to be those who experienced less benefit (e.g., due to poor adherence), the results could overestimate the true effect. The authors report no baseline differences between dropouts and completers, but this is not definitive.

**No dietary or sleep monitoring** — both can affect telomere biology. If participants in the endurance groups spontaneously improved their diet or sleep (e.g., due to increased health awareness), this could confound results.

**Short follow-up (6 months)** — we don't know if the telomere lengthening persists, plateaus, or reverses with continued training. Longer studies (1–2 years) are needed.

**No dose-response analysis** — participants trained 3×/week for 45 minutes, but we don't know if more or less training would produce different effects. The optimal "dose" for telomere maintenance is unknown.

**Industry funding** — the study was funded by the German Research Foundation (DFG) and the Saarland University, with no apparent industry ties. However, the exercise equipment for resistance training was provided by a manufacturer (gym80 International), which could introduce subtle bias (though unlikely given the results favored endurance over resistance training).

**Population limits** — all participants were healthy, non-smoking, and previously inactive. Results may not apply to smokers, people with chronic diseases, or already-active individuals. The effects might be smaller in people who are already fit (ceiling effect) or larger in people with worse baseline telomere length.

**No correction for multiple comparisons** — the authors report p-values without adjusting for the fact that they tested multiple outcomes (telomerase, telomere length in three cell types, VO₂max). Some significant results could be false positives, though the consistent pattern across cell types and the correlation between telomerase and telomere length argue against this.

For someone running their own n=1 experiment:

### What to test

**Intervention:** 45 minutes of continuous running at moderate intensity (60–70% of heart rate reserve, or a pace where you can still hold a conversation) OR 4×4 interval training (4 minutes at 90–95% max heart rate, 3 minutes active recovery, repeated 4 times). Do this 3 times per week.

**Comparator:** Either a period of no exercise (control) or a period of resistance training (e.g., 45 minutes of circuit weight training 3×/week) to see if the effect is specific to aerobic exercise.

**Dose:** 3 sessions per week, 45 minutes each, for at least 6 months. The acute effects appear after a single session, but the chronic telomere lengthening took 6 months to become statistically significant.

### Minimum meaningful duration

**For acute effects (telomerase activity):** A single session — measure telomerase activity in blood before and immediately after exercise, and 1 hour post-exercise.

**For chronic effects (telomere length):** At least 3 months (the study saw trends at 3 months but significant changes only at 6 months). A minimum of 6 months is recommended for a self-experiment.

### What to measure

**Primary metric:** Telomere length in leukocytes (or specifically in lymphocytes). This requires a blood draw and a specialized lab (qPCR or flow-FISH). Some direct